Author

HA Bouchebout

Institution: University of Algiers Benyoucef Benkhedda

Observed institution: University of Algiers Benyoucef Benkhedda

OpenAlex ID: A5115636866

EE290 Cost Comparison Between the Use of Pertuzumab-Trastuzumab SC and IV Formulations to Treat HER2+ Breast Cancer Patients in Algeria

2024 · M Hedibel, HA Bouchebout, et al. · Value in Health

Works count: 1

Citation count:

H-index:

I10-index: